[The studies on the individualized treatment and hormonal patterns during the administration of HMG-HCG in anovulatory women (author's transl)].
Repeatedly, we tried to give an devized treatment of HMG-HCG therapy to the three women who had different degree ovulatory disorder. Throughout the study, we observed BBT, cervical mucus and the changes of blood hormones levels until all three women got pregnant. 1) As much difference was bound in the individual ovarian sensitivity to gonadotropin, we observed the ovarian reaction administering of HMG (150 IU) every day. 2) When we observed some maturity of ovarian follicles, we decreased amount of HMG to the level of FSH in the normal menstrual cycle. 3) Considering the days needed to form follicular maturation, we changed HMG to HCG 4 or 5 days after cervical mucus increased to 0.2 ml. or more and showed 2-grade of crystallization.
D000328:Adult; D000858:Anovulation / Q000097:blood / Q000188:drug therapy*; D006063:Chorionic Gonadotropin / Q000008:administration & dosage* / Q000627:therapeutic use; D002996:Clomiphene / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D005498:Follicular Phase; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008596:Menotropins / Q000008:administration & dosage* / Q000627:therapeutic use
D006063:Chorionic Gonadotropin; D002996:Clomiphene; D004958:Estradiol; D008596:Menotropins; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone